RYAN PRICE: Open Payments
NPI 1013429000 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,253 in 157 payments from 27 companies in 2025. Trend: 2023 $3,527 · 2024 $3,629 · 2025 $3,253
Food & beverage: $3,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $468 |
| UCB, Inc. | 20 | $397 |
| Biogen, Inc. | 12 | $292 |
| Eisai Inc. | 11 | $278 |
| Neurocrine BioSciences, Inc. | 15 | $252 |
| Novartis Pharmaceuticals Corporation | 11 | $194 |
| ANI Pharmaceuticals, Inc. | 5 | $177 |
| TG Therapeutics, Inc. | 3 | $172 |
| Mallinckrodt Hospital Products Inc. | 3 | $159 |
| ACADIA Pharmaceuticals Inc | 8 | $158 |
Products named: Zilbrysq, Leqembi, QULIPTA, INGREZZA, PURIFIED CORTROPHIN GEL, KESIMPTA, BRIUMVI, VUMERITY.
Industry payments across AZ — which companies pay providers there.
